Germline BRCA1 Deletion as Driver Mutation for Metastatic Urachal Adenocarcinoma in Patient Who Achieved Complete Response to Rucaparib.

Germline BRCA1 Deletion as Driver Mutation for Metastatic Urachal Adenocarcinoma in Patient Who Achieved Complete Response to Rucaparib. J Oncol Pract. 2019 Apr 02;:JOP1800708 Authors: Seto T, Pujare D, Song MN, Lee J, Huber R, Sam D, Pan M PMID: 30939057 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30939057?dopt=Abstract

Source: JOP - April 1, 2019 Category: Gastroenterology Authors: Seto T, Pujare D, Song MN, Lee J, Huber R, Sam D, Pan M Tags: J Oncol Pract Source Type: research

More News: Adenocarcinoma | Gastroenterology | Urachal Carcinoma